Strength
40 mg/1
Manufacturer
AvPAKNDC
50268009515
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATEApproval Type
Generic (ANDA)
FDA Application
ANDA090548On Market Since
6/28/2016
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 450 times since Nov 15, 2017, and over the history we have for it it has declined 68.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0379 per EA |
|---|---|
| All-time high | $0.1257 (Sep 12, 2018) |
| All-time low | $0.0379 (Jun 17, 2026) |
| 52-week high | $0.0463 |
| 52-week low | $0.0379 |
| Median price | $0.0630 |
| Average price | $0.0708 |
| Largest weekly change | +27.7% (Aug 21, 2024) |
| Weeks tracked | 450 |
| Tracking since | Nov 15, 2017 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by AvPAK, is $0.0379 per EA (NDC 50268009515), effective Jun 24, 2026.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 68.5%. It has been tracked across 450 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Nov 15, 2017, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0379 (Jun 17, 2026) to a high of $0.1257 (Sep 12, 2018), with a median of $0.0630 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as ATORVASTATIN 40 MG TABLET, but none are currently priced below it.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 50268009515) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification